NCT05141890View on ClinicalTrials.gov

Probiotics for Inflammation in Pediatric Chronic Pain

NAActive, not recruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

August 1, 2024

Study Completion Date

December 1, 2025

Conditions
Chronic PainBody Mass Index >=85th Percentile
Interventions
DIETARY_SUPPLEMENT

Lactobacillus Plantarum

Dietary Supplement: Lp299v. Lp299v is a commercially available probiotic supplement manufactured and distributed by Next Foods.

Trial Locations (1)

53185

Children's Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER